← All organizations

Kinevant Sciences GmbH

For profit

Also known as: Kinevant Sciences | Kinevant Sciences GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 30, 2022

Acquired by Roivant Sciences, Inc. → Sumitomo → Sumitomo Dainippon on Dec 21, 2018

Timeline

2000s

Jan 1, 2005
Sumitomo Dainippon— Now

2010s

Dec 21, 2018
Kinevant Sciences GmbH— Founded
Dec 21, 2018
Roivant Sciences, Inc.— Acquired By

Drugs by trial phase (2 distinct, 4 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (6)

NCT05351554Lead sponsorPhase 2Jun 30, 2022
NCT05351554Study directorPhase 2Jun 30, 2022
NCT05314517Lead sponsorPhase 2Apr 30, 2022
NCT05314517Study directorPhase 2Apr 30, 2022
NCT04351243Lead sponsorPhase 2Apr 30, 2020
NCT04205851Lead sponsorPhase 1Nov 12, 2019

Details

Founded: Basle-City, CH Dec 21, 2018
Last known activity: Jun 30, 2022